GlassScriptPhysician profile
Nicola A Pemberton
NPI 1306030507
$1,528.59
in general payments reported to CMS, 2019-2025
26 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $147 · 2021: $208 · 2022: $192 · 2023: $324 · 2024: $166 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $631.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $217.19 | 2021-2025 | Phexxi, Solosec, Phexx |
| Lupin INC. | $195.45 | 2019-2021 | |
| Abbvie INC. | $192.68 | 2019-2023 | |
| Progenics Pharmaceuticals, INC. | $125.00 | 2023 | Pylarify |
| Organon LLC | $113.02 | 2023-2025 | Nexplanon |
| Astellas Pharma US INC | $101.05 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $65.92 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $59.16 | 2019-2024 | Gardasil 9, Gardasil |
| Vertical Pharmaceuticals, LLC | $56.06 | 2019 | |
| Exeltis, USA INC. | $53.52 | 2020-2022 | |
| Amag Pharmaceuticals, INC. | $52.30 | 2019 | |
| Becton, Dickinson and Company | $39.61 | 2021-2022 | |
| Coopersurgical, INC. | $39.27 | 2020-2021 | |
| Duchesnay USA Incorporated | $28.59 | 2019 | |
| Hologic Sales and Service, LLC | $28.15 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $19.29 | 2023 | Accrufer |
| Agile Therapeutics, INC. | $15.38 | 2022 | |
| Scynexis, INC. | $15.00 | 2022 | |
| Mylan Pharmaceuticals INC. | $15.00 | 2022 | |
| Myovant Sciences INC. | $15.00 | 2022 | |
| Daiichi Sankyo INC. | $14.87 | 2020 | |
| Allergan, INC. | $14.53 | 2019 | |
| Kesin Pharma Corporation | $14.43 | 2023 | Likmez |
| Avion Pharmaceuticals | $13.33 | 2021 | |
| Aspira Women'S Health INC | $12.71 | 2019 | |
| Avanos Medical | $12.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicola Pemberton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.